7 reports

  • MYOCARDIAL INFARCTION - PIPELINE BY CYNATA THERAPEUTICS LTD, H1 2018
  • SMALL MOLECULES TO SCAVENGE FREE RADICALS FOR OXIDATIVE STRESS RELATED DISORDERS - DRUG PROFILE

Myocardial Infarction - Pipeline Review, H1 2018 Summary Global Markets Direct’s latest Pharmaceutical and Healthcare disease pipeline guide Myocardial Infarction - Pipeline Review, H1 2018, provides an overview of the Myocardial Infarction (Cardiovascular) pipeline landscape. Myocardial infarction...

  • Cell Therapy
  • Heart Attack
  • United States
  • World
  • Product Initiative

NO has a solid place in asthma management.

  • Drug Test
  • United States
  • Alere Inc.
  • Dräger Group
  • Thermo Fisher Scientific, Inc.

The small molecules were also under development for asthma and rheumatoid arthritis.

  • Chronic Disease
  • Heart Attack
  • Therapy
  • United States
  • Product Initiative
  • SMALL MOLECULES TO ANTAGONIZE ADENOSINE A2B RECEPTOR FOR ASTHMA AND MYOCARDIAL INFARCTION - DRUG PROFILE
  • Research and Development Brief

Myocardial Infarction - Pipeline Review, H2 2017 Summary Global Markets Direct’s latest Pharmaceutical and Healthcare disease pipeline guide Myocardial Infarction - Pipeline Review, H2 2017, provides an overview of the Myocardial Infarction (Cardiovascular) pipeline landscape. Myocardial infarction is the irreversible...

  • Chronic Disease
  • Heart Attack
  • United States
  • Product Initiative
  • Athersys, Inc.

The molecules developed by Companies in Phase II and Preclinical stages are ## and ## respectively.

  • Heart Attack
  • Therapy
  • World
  • Product Initiative
  • CicloMulsion AG
  • 5. ALL THE TRIALS INCLUDED ARE UNIQUE TRIALS.

THE PROMINENT FEATURES OF THIS REPORT ARE - ##.

  • Cardiovascular Disease
  • Clinical Trial
  • Heart Attack
  • Hospital
  • World
  • Clinical Trial Profile Snapshots

The prominent features of this report are - ##.

  • Clinical Trial
  • Drug Discovery And Development
  • Heart Attack
  • Therapy
  • World